Jenburkt Pharmaceuticals Ltd
BSE:524731
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Jenburkt Pharmaceuticals Ltd
BSE:524731
|
IN |
|
C
|
Chesnara PLC
LSE:CSN
|
UK |
|
V
|
Visa Inc
F:3V64
|
US |
|
I
|
Integer Holdings Corp
NYSE:ITGR
|
US |
|
Charter Communications Inc
NASDAQ:CHTR
|
US |
|
M
|
Mattel Inc
XHAN:MTT
|
US |
|
Societatea de Producere a Energiei Electrice in Hidrocentrale Hidroelectrica SA
F:E28
|
RO |
|
A
|
Akwel SA
SWB:MW4
|
FR |
|
E
|
EQT AB
OTC:EQBBF
|
SE |
|
S
|
SLB NV
XHAM:SCL
|
US |
|
Aviva PLC
LSE:AV
|
UK |
|
Informa PLC
LSE:INF
|
UK |
|
C
|
Comture Corp
TSE:3844
|
JP |
|
C
|
Cherrybro Co Ltd
KOSDAQ:066360
|
KR |
|
Delivery Hero SE
OTC:DLVHF
|
DE |
|
C
|
Credit Agricole SA
XHAM:XCA
|
FR |
|
Prada SpA
HKEX:1913
|
IT |
|
K
|
Kasikornbank PCL
DUS:TFBF
|
TH |
|
C
|
CEMATRIX Corp
OTC:CTXXF
|
CA |
|
Coherus Oncology Inc
NASDAQ:CHRS
|
US |
|
S
|
Southern Co
XHAM:SOT
|
US |
Bankruptcy Probability
Jenburkt Pharmaceuticals Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Jenburkt Pharmaceuticals Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IN |
|
Jenburkt Pharmaceuticals Ltd
BSE:524731
|
4.2B INR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.3T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
655.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
391.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
362.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
253.3B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
217.8B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.2T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
167.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
129B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Sanofi SA
PAR:SAN
|
100.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Jenburkt Pharmaceuticals Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Jenburkt Pharmaceuticals Ltd has total debt of 18.4m INR. This includes both short-term (0 INR) and long-term (18.4m INR) debt.
You can find a full breakdown on its Balance Sheet.
